Physician profile
Deborah A Terrell
NPI 1629366653
$1,633.54
in general payments reported to CMS, 2019-2025
13 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $262 · 2023: $195 · 2024: $556 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $365.52 | 2024-2025 | Epclusa, Livdelzi |
| Abbvie INC. | $191.76 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2025 | Spravato |
| Amgen INC. | $124.55 | 2024 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.90 | 2021 | |
| Electromed, INC. | $97.61 | 2022 | |
| Grifols USA, LLC | $95.20 | 2023 | Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $93.88 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.57 | 2024 | Xifaxan |
| Allergan, INC. | $88.09 | 2021 | |
| Esperion Therapeutics, INC. | $87.91 | 2021 | |
| Nestle Healthcare Nutrition INC. | $83.50 | 2022 | |
| Novo Nordisk INC | $81.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.